The Nu Ride Inc. (NRDE) SEC filings page provides access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. Nu Ride Inc., a U.S. auto manufacturers company in the consumer cyclical sector, emerged from Chapter 11 bankruptcy under a confirmed plan of reorganization and now trades on the OTC Pink Market. Its filings document this transition, ongoing governance decisions, and material legal and financial developments.
Through Forms 8-K, Nu Ride Inc. reports significant events such as leadership changes, amendments to engagement letters with advisory firms, court orders affecting its general unsecured creditor claims reserve, and stockholder approvals of amendments to its equity incentive plan and NOL Protective Provisions. These current reports also incorporate by reference detailed descriptions from definitive proxy statements and filed exhibits, including the 2020 Equity Incentive Plan and the NOL Protective Amendment to the Third Amended and Restated Certificate of Incorporation.
The company’s definitive proxy statement on Schedule 14A outlines the agenda for its virtual annual meeting of stockholders, proposals for the election of directors, ratification of its independent registered public accounting firm, advisory votes on executive compensation and its frequency, and amendments to equity and NOL protection arrangements. It also describes corporate governance structures, board committees, executive compensation, and securities authorized for issuance under equity compensation plans.
On this page, users can review Nu Ride Inc.’s Forms 8-K, proxy statements, and other SEC documents as they are made available through EDGAR. AI-powered tools can help summarize lengthy filings, highlight key governance and litigation disclosures, and make it easier to understand how court decisions, stockholder votes, and contractual arrangements affect the company’s capital structure and post‑reorganization framework.
Nu Ride Inc. reported a leadership change and updated its advisory arrangement. Effective September 26, 2025, the board appointed Alexander C. Matina as Chief Executive Officer, President, Treasurer, Secretary and principal financial officer, succeeding William Gallagher, whose role was provided through M3 Advisory Partners.
The company amended its engagement letter with M3 Advisory Partners so M3 continues to support operations, assets, liabilities and related matters, but without supplying the CEO. Under his new employment agreement, Mr. Matina will receive a $415,000 annual base salary, annual RSU grants valued at $50,000 as CEO and $110,000 as a board member, plus $4,000 per month for outside healthcare and potential discretionary bonuses.